Skip to main content

Press release

Paris, 5 May 2022

Levine Keszler advises Sparring Capital on its majority LBO of Praticima

Sparring Capital acquires a majority stake in the Praticima group. This transaction enables Stage Capital to sell its stake and several senior executives to acquire a stake in the group.

The Praticima group, formed in 2014 from the merger of Praticdose, Cima and Adhesia Equipements, is the French market leader in equipment for medication circuits and healthcare workflow management for healthcare facilities (hospitals, clinics, nursing homes, etc.) and medical equipment distributors.

With nearly 100 employees, two production sites in France (Reyrieux in the Ain department and Avranches in the Manche department) and a commercial presence in 50 countries, the group is targeting turnover of €25 million in 2022.

Praticima develops and manufactures equipment ranges, developed in partnership with healthcare professionals and designed by an in-house design office. Recognised for the innovative nature of its solutions, the group stands out for its unique ability to respond to the specific concerns of its customers, such as promoting the well-being of healthcare staff and ensuring the safe administration of medicines.

With the support of Sparring Capital, Praticima aims to accelerate its development through the ramp-up of its recent innovations and its international expansion. The roll-out of an external growth strategy in France and internationally is also a priority development area for the group.

As part of the transaction, Fabrice Léo, the current managing director, will take over as chairman of the group, succeeding Régis Guitard, who will remain a shareholder and continue to support Praticima on strategic issues.

Levine Keszler advised Sparring Capital.

The full press release is attached.